Major Depressive Episode clinical trials

Explore recruiting major depressive episode clinical trials.

Recruiting major depressive episode studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Major Depressive Episode trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Cerebral neuroinflammation during major depressive episode: multicentric comparative study (InflaDep)

France

Therapeutic use (Phase IV) EU CTIS Study details

Add-on buprenorphine at analgesic doses for the treatment of severe suicidal ideas during a major depressive episode

France

Therapeutic exploratory (Phase II) EU CTIS Study details

CombiChronoS - Effectiveness of a Combination of Chronotherapeutics for the Treatment of Major Depressive Episode (MDE) with Insomnia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 2x2 Factorial Trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

MOODBOOSTER« Early efficacy of ketamine compared to placebo, in add-on therapy of venlafaxine for inpatients with severe unipolar major depressive episodes: a double blind randomized controlled trial »

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multi-centre, double-blind, placebo-controlled, randomised trial to prove the efficacy and safety of Silexan® (WS®1265) in patients with a major depressive episode of mild to moderate severity

Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and Safety of Daridorexant in Patients with Major Depressive Disorder (MDD) and Insomnia: Double-blind, randomized, controlled trial

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Major Depressive Episode trials by city

Major Depressive Episode clinical trials

Recruiting major depressive episode studies right now

Comparing Uni- and Bi-lateral TBS in Major Depression

The Impact of Coach-guided Risk Communication on the Risk of Major Depression

Belief Update: The Effects of Depression and Antidepressants in Older People

tDCS: Sleep to Mood in Depression (S2M-D)

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression

Effectiveness of MST Versus ECT for Major Depressive Episode

Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.

A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects

EEG Microstates Across At-Risk Mental States

Feasibility and Efficacy of rTMS in Depression in Patients With Autism Spectrum Disorder (ASD)

Also recruiting in Europe

Cerebral neuroinflammation during major depressive episode: multicentric comparative study (InflaDep)

Add-on buprenorphine at analgesic doses for the treatment of severe suicidal ideas during a major depressive episode

CombiChronoS - Effectiveness of a Combination of Chronotherapeutics for the Treatment of Major Depressive Episode (MDE) with Insomnia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 2x2 Factorial Trial

MOODBOOSTER« Early efficacy of ketamine compared to placebo, in add-on therapy of venlafaxine for inpatients with severe unipolar major depressive episodes: a double blind randomized controlled trial »

Multi-centre, double-blind, placebo-controlled, randomised trial to prove the efficacy and safety of Silexan® (WS®1265) in patients with a major depressive episode of mild to moderate severity

Efficacy and Safety of Daridorexant in Patients with Major Depressive Disorder (MDD) and Insomnia: Double-blind, randomized, controlled trial

Major Depressive Episode trials by city

Other conditions